Gregory V. Kryukov

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract 7092: Highly potent and mutant-selective p53 Y220C reactivators with best-in-class potential

  Cancer Research · 2026-04-03

• Dual-inactivation of Regnase-1 and SOCS1 rewires exhausted CD8 ⁺ T cell fate to enhance anti-tumor functionality

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-01-23 · 3 citations

• Supplementary Figures1 from STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer ModelsPreprint

  2025-07-15

• Data from STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer ModelsPreprint

  2025-07-15

• Supplementary Tables1 from STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models

  2025-07-15

• Supplementary Methods1 from STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer ModelsPreprint

  2025-07-15

• STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models

  Clinical Cancer Research · 2025-06-04 · 5 citations